Author: klseear
Report
Uncategorized
New report from a national consultation on data-driven methods and health care
We have recently completed a major national consultation on the emergence of a range of data-driven methods intended to support the health needs of people who use illicit drugs and those with related health issues, such as hepatitis C. The consultation explored expert understandings of these methods, how and why these methods are being developed and […]
Read More
Project update
Research
Thinking dignity and freedom this Human Rights Day
Each year on the 10th of December, the United Nations celebrates International Human Rights Day. In 2022, the theme for the day is ‘Dignity, freedom and justice for all’. In January 2021, our program lead, Associate Professor Kate Seear, commenced her Australian Research Council-funded Future Fellowship, exploring the intersections between human rights, drug policy and gender. The […]
Read More
Research
New research raises concerns about hepatitis C post-cure life
We are pleased to announce the next publication from our ARC-funded project, ‘Addressing hepatitis C-related legal, policy and practice discrimination in a post-cure world’. Co-authored by GLaD program lead Kate Seear, with Suzanne Fraser, Sean Mulcahy, Dion Kagan, Emily Lenton, Adrian Farrugia and kylie valentine, and published in the international journal Social and Legal Studies, […]
Read More
Presentation
The launch of the Global Drug Policy Index
GLaD program lead Kate Seear recently joined colleagues from around Australia for a special panel event to mark the launch of the inaugural Global Drug Policy Index. The Index measures and compares national-level drug policies, including their implementation, against the UN’s Common Position on Drugs. The Index assesses and ranks the performance of countries across […]
Read More